# ABO-GLYC in Type 2 Diabetes

> **NCT03568409** · NA · COMPLETED · sponsor: **Aboca Spa Societa' Agricola** · enrollment: 86 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DEVICE:** ABO-GLYC
- **OTHER:** ABO-GLYC Placebo

## Key facts

- **NCT ID:** NCT03568409
- **Lead sponsor:** Aboca Spa Societa' Agricola
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2022-06-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03568409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03568409, "ABO-GLYC in Type 2 Diabetes". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03568409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*